Growth Metrics

Phibro Animal Health (PAHC) Depreciation & Amortization (CF) (2016 - 2026)

Phibro Animal Health has reported Depreciation & Amortization (CF) over the past 13 years, most recently at $12.9 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 11.38% year-over-year to $12.9 million; the TTM value through Dec 2025 reached $50.7 million, up 30.21%, while the annual FY2025 figure was $45.6 million, 26.06% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $12.9 million at Phibro Animal Health, roughly flat from $12.8 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $12.9 million in Q4 2025 and troughed at -$24.0 million in Q2 2021.
  • A 5-year average of $7.5 million and a median of $8.7 million in 2023 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): tumbled 99.94% in 2021 and later skyrocketed 168900.0% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $8.0 million in 2021, then rose by 6.22% to $8.5 million in 2022, then rose by 4.84% to $8.9 million in 2023, then increased by 29.9% to $11.6 million in 2024, then grew by 11.38% to $12.9 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for PAHC at $12.9 million in Q4 2025, $12.8 million in Q3 2025, and $12.4 million in Q2 2025.